Concenter BioPharma created a new non-steroidal anti-inflammatory drug called Zygosid-50 that targets the disease at its source by restoring the body’s sensitivity to insulin
https://www1.cbn.com/cbnnews/israel...ld-be-a-game-changer-for-millions-of-patients
https://www1.cbn.com/cbnnews/israel...ld-be-a-game-changer-for-millions-of-patients